The impact of the FDA 2014 power morcellation safety communication on CHS gynecologic surgeon practice patterns

被引：0

|

作者：

Taylor, G. B. ^{[1
]}

Earles, E. ^{[1
]}

Kaczmarski, K. ^{[1
]}

机构：

[1] Carolinas Healthcare Syst, Obstet & Gynecol, Charlotte, NC USA

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2018年 / 218卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

19

引用

收藏

页码：S905 / S905

页数：1

相关论文

共 45 条

[41] Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: Opening Pandora's suicide box
Lineberry, Timothy W.
Bostwick, J. Michael
Beebe, Timothy J.
Decker, Paul A.
MAYO CLINIC PROCEEDINGS, 2007, 82 (04) : 518 - 520
[42] IMPACT OF TESTOSTERONE REPLACEMENT THERAPY IN MEN WITH ADULT ONSET HYPOGONADISM AFTER ISSUANCE OF 2014 FOOD AND DRUG ADMINISTRATION SAFETY COMMUNICATION
Talwar, R.
DiGiorgio, L.
Shin, D.
JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E55 - E55
[43] Impact of the 2012 FDA safety communication on drosperinone containing oral contraceptives - Detection bias in the international active surveillance - Folate and oral contraceptives utilization study (INAS-FOCUS)
Barnett, Clare
Bauerfeind, Anja
Thai Do Minh
Heinemann, Klaas
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 586 - 586
[44] ANALYSIS OF THE IMPACT OF AFFORDABLE CARE ACT AND THE 2011 FDA SAFETY COMMUNICATION ON THE UTILIZATION OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN THE MEDICAID OUTPATIENT PHARMACY PROGRAM
Alghamdi, A.
Seoane-Vazquez, E.
Rodriguez-Monguio, R.
VALUE IN HEALTH, 2017, 20 (05) : A152 - A152
[45] Impact of Long-Term Safety Data and FDA Warnings on Drug-Eluting Stent Use in Clinical Practice: A Report from the ACC/National Cardiovascular Data Registry
Krono, Ronald J.
Rao, Sunil V.
Dai, David
Paterson, Eric D.
Shaw, Richard E.
Klein, Lloyd W.
Anderson, H. V.
Weintraub, William S.
Brindis, Ralph G.
CIRCULATION, 2008, 118 (18) : S897 - S897

← 1 2 3 4 5 →